616 — Louisville, Kentucky

616 is a clinical research site located in Louisville, Kentucky, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

616 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB BIOSCIENCES, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 616?

616 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 616 conducted?

616 has 1 clinical trials on record. Their work covers Epilepsy.

Is 616 accredited by Crixeo Health?

616 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 616?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.